Divis Laboratories reports 63% surge in Q1 net profit

Divis Laboratories has reported results for first quarter ended June 30, 2012.

The company has registered a rise of 63.15% in its net profit at Rs 167.38 crore for the quarter under review as compared to Rs 102.59 crore for the same quarter in the previous year. The total income from operation of the company has increased by 36.13% at Rs 510.17 crore for Q1FY13 as compared Rs 374.78 crore for the corresponding quarter previous year.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.